pocketful logo
Indegene Ltd logo

Indegene Ltd

NSE: INDGN BSE: 544172

₹440.65

(-1.12%)

Mon, 30 Mar 2026, 05:57 am

mtf coin illustrationMTF 5x

Indegene Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    10881.85

  • Net Profit

    406.70

  • P/B

    5.30

  • Sector P/E

    53.74

  • P/E

    34.05

  • EV/EBITDA

    21.16

  • Debt/Equity (Industry)

    0.39

  • Interest Cover (Industry)

    5.75

  • ROCE (Industry)

    12.26

  • RONW (Industry)

    12.05

  • ROE

    20.11

  • ROCE

    23.31

  • Debt/Equity

    0.15

  • EPS (TTM)

    18.23

  • Dividend Yield

    0.44

  • Book Value

    119.01

  • Interest Cover

    25.51

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters00000
FII11.4811.3010.055.245.03
DII8.076.967.204.963.98
Public80.4581.7482.7589.8090.99
Government00000

Read More

Technical Analysis

RSI

46.66

MACD

-8.61

50 DMA

470.57

200 DMA

531.00

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic592.02540.77518.53489.52467.28438.27387.02
Fibonacci540.77521.19509.09489.52469.94457.84438.27
Camarilla510.39505.70501.00489.52491.60486.90482.21

Pivots Level: Classic

R3

+102.50

592.02

R2

+51.25

540.77

R1

+29.02

518.53

489.52
489.52
Pivot Point
LTP: 449.95

S1

-22.23

467.28

S2

-51.25

438.27

S3

-102.50

387.02

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    447.71

  • 20-EMA

    453.11

  • 30-EMA

    459.54

  • 50-EMA

    470.92

  • 100-EMA

    492.55

  • 200-EMA

    519.63

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
29 Jan 2026board-meetingsQuarterly Results, Employee Stock Option
30 Oct 2025board-meetingsQuarterly Results, Employee Stock Option
27 May 2025agm
13 May 2025dividendFinal Dividend - Rs. - 213 Jun 2025
28 Apr 2025dividend₹2.00 Dividend /Share13 Jun 2025
06 Aug 2024agm
29 Jul 2024agmAnnual General Meeting30 Aug 2024

Read More

Peer Comparison

Indegene Ltd logo

Indegene Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Read More

Indegene Ltd About

Indegene is a strengthened its positioning as a global, differentiated business entity, committed to applying cutting-edge technology and contemporary practices to modernize healthcare.

Industry

Miscellaneous

Founded

1998

Headquarters

CEO

Manish Gupta

Employees

Contact

Website icon

Website

http://www.indegene.com

Email icon

Email

compliance.officer@indegene.com

Phone icon

Phone

91-80-4674 4567/+91-80-4644 7777

Location icon

Location

Aspen Block G4 3rd Flr Manyata, Embassy Busi. Park Nagawara, Bengaluru, Karnataka, 560045

Read More

Indegene Ltd Company History

YearHistory
2020
  • Acquired DT Associates Research and Consulting Services Limited, a consulting services company in UK.
  • Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences.
2021
  • Expanded operations to Japan by incorporating Indegene Japan, LLC.
  • Raised equity funding from CA Dawn Investments and Brighton Park Capital.
  • Received BS ISO/IEC 27701:2019 certification for privacy information management system.
2022
  • Acquired Medical Marketing Economics, LLC, and subsequently merged it with Indegene, Inc.
  • Expanded global operations with new offices in Mexico.
  • Converted from a private limited company to a public limited company.
  • Changed the company name to Indegene Limited.
2023
  • Acquired Cult Health, a company providing advertising services to parties in the healthcare sector.
  • Acquired Indegene Healthcare Germany GmbH, expanding presence in Europe.
  • Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform.
2024
  • Acquired Trilogy Writing & Consulting GmbH, a company providing high-end medical writing to customers.
  • Acquired three wholly owned subsidiaries of Trilogy Writing & Consulting GmbH.
  • Ranked 167 in The Next 500 India's Largest Emerging Companies by Fortune India.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
IRAGE BROKING SERVICES LLPBuy38403959204 Jun 2025
SOCIETE GENERALE - ODIBuy187977559104 Jun 2025
MANSI SHARE AND STOCK ADVISORS PVT LTDSell1422279592.0604 Jun 2025
IRAGE BROKING SERVICES LLPSell3348661592.904 Jun 2025
ABAKKUS EMERGING OPPORTUNITIES FUND-1Buy1210000591.4804 Jun 2025
IRAGE BROKING SERVICES LLPSell422811592.2204 Jun 2025
EAST BRIDGE CAPITAL MASTER FUND I LIMITEDBuy216800059104 Jun 2025
MANSI SHARE AND STOCK ADVISORS PVT LTDBuy1160489592.0304 Jun 2025
PI OPPORTUNITIES AIF V LLPBuy169204759104 Jun 2025
SMALLCAP WORLD FUND INCBuy182785659104 Jun 2025

Read More

Indegene Ltd News

Indegene Responds to BSE Price Movement Query

Indegene Limited clarifies to BSE that no undisclosed material events are pending following inquiry about significant price and volume movements in company securities.

24 Mar 2026

companies

Indegene Board Approves RSU Share Allotment Plan

Indegene Limited's Board of Directors passed resolutions on March 18, 2026, approving share allotments under the RSU 2020 plan through circulation, covering both bonus and non-bonus elements.

18 Mar 2026

companies

Indegene Clarifies No Material Events Behind Volume Surge

Indegene Limited responds to BSE inquiry about increased trading volume, confirming no pending undisclosed material events affecting stock price or trading activity as of March 16, 2026.

16 Mar 2026

companies

Indegene Schedules Investor Meeting for March 18, 2026

Indegene Limited announces investor/analyst meeting with Authum Investment scheduled for March 18, 2026 in Bengaluru. The in-person 1x1 meeting complies with SEBI disclosure regulations.

13 Mar 2026

companies

Indegene acquires two UK healthcare consulting firms

Indegene Limited's subsidiary signs agreement to acquire 100% equity in DT Associates Research and Consulting Services Limited and Trilogy Writing and Consulting Limited for £2.70 million combined.

01 Mar 2026

co actions results

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800